United Therapeutics | UTHR - Cost Of Sales



United Therapeutics reported $175.2M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Amarin USD 16.89M 18.51M Mar/2025
Ardelyx USD 14.82M 3.44M Jun/2025
Baxter International USD 1.82B 55M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Biogen USD 605M 24.3M Jun/2025
BioMarin Pharmaceutical USD 154.94M 3.38M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Halozyme Therapeutics USD 64.12M 15.72M Jun/2025
Insmed USD 29.34M 8.06M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
J&J USD 7.6B 304M Jun/2025
Moderna USD 119M 29M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
PTC Therapeutics USD 15.48M 2.62M Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Sarepta Therapeutics USD 153.22M 15.66M Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025
United Therapeutics USD 175.2M 102.3M Jun/2025
Vertex Pharmaceuticals USD 407.5M 44.5M Jun/2025